Vodafone Certified application status for the MedifyRemote™ application

vodafoneMedify Solutions Limited announced that it has been awarded Vodafone Certified application status for its MedifyRemote™ application. MedifyRemote™ is the first application of its type and allows healthcare professionals mobile access to review and update a patients' medical history records in a single, secure session via a standard Microsoft Windows Mobile PDA/phone device. The application offers no interference with the existing device functions, enabling one device to be utilised for telephone, email, calendar, internet access; as well patient note functions.

In order to achieve Vodafone Certified status, MedifyRemote™ underwent technical evaluation by Vodafone UK. As a result, the application has passed the approval process, meeting the high standards demanded by Vodafone UK's customer base and delivering value to the UK marketplace.

As a Certified application, Medify Solutions Limited now has access to Vodafone UK's technical expertise and will be recommended to appropriate customers by Vodafone UK account managers. MedifyRemote™ will be identified by the "Vodafone Certified Application" brand logo. This will allow Medify Solutions Limited to benefit from Vodafone UK's position as the UK's largest mobile network operator, offering its customers in-depth support and peace of mind when deploying new mobile applications.

Ian O'Reilly, CEO Medify Solutions Limited, said: "Gaining Vodafone Certified status represents a superb endorsement for the MedifyRemote™ application. Our mobile application is successfully leading the way in the UK NHS and the rapid development of the e-Healthcare sector. The recognition of the importance of MedifyRemote™ by a major organisation such as Vodafone UK, underlines the value that this application delivers to clinical users and partners alike. We are very much looking forward to continuing the strong partnership we have formed with Vodafone UK."

Nick Parbutt, Head of Enterprise Product, Vodafone UK said: "For many of our customers, mobile data applications, such as job scheduling or workforce management are a business imperative. Having experienced the business benefits that such applications deliver, these customers are now considering additional solutions to address day-to-day business requirements. Medify Solutions Limited has proven that it can address these needs and we look forward to working with its team to enable our customers to realise the efficiencies that MedifyRemote™ delivers."

MedifyRemote™ joins a number of other Certified application developers in the Vodafone UK applications portfolio which have developed solutions ranging from telematics and sales solutions to tools that replicate the functionality or content from the desktop environment on to the mobile device.

Those interested in further information should email This email address is being protected from spambots. You need JavaScript enabled to view it. or visit www.medifysolutions.com

About the Medify Solutions
The Medify Solutions group of companies are focused on the development, taking to market and delivery of leading edge mobile solutions for the healthcare market. With operations across the EU, Medify are at the forefront of the technology revolution in patient care. For more information, please visit www.medifysolutions.com.

About Vodafone UK
Vodafone UK has 16.3 million customers and is part of the world’s leading international mobile telecommunications Group, offering a wide range of voice and data communications. The company is committed to providing mobile solutions that allow both consumer and business customers to make the most of now. In addition, Vodafone connects customers across the globe with roaming agreements worldwide. It provides 3G roaming in 29 countries and offers great roaming value with Vodafone Passport. For more information, please visit www.vodafone.co.uk.

Most Popular Now

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...